TELO
Telomir Pharmaceuticals, Inc. Common Stock
Mentions (24Hr)
140.00% Today
Reddit Posts
Mentions
TELO has analyst projections of 15$ I’m calling it
TELO is the play for tomorrow!!!!
Do not sleep on TELO guys… promising AH
guys please don’t sleep on TELO, huge news and a promising looking AH, don’t say i didnt warn you guys
TELO is the play tomorrow
Anyone buying TELO in AH?
You could check out TELO. Do your research, very interesting.
TELO could be huge. Recommend to everyone to check it out. NFA do your due diligence obviously.
TELO it's not going to be under $2 for long.
what you think will be best play pre market tomorrow? RVPH or TELO
I’m in for PSTV TELO RDZN
TELO 🚀🚀🚀 Great news for it tomorrow
just chucked a small 400 share position on TELO just because people have been saying it, seems to be stuck at $2 for now
TELO about to go crazy tomorrow. Low volume right now cuz it’s AH
TELO is the move for tomorrow I think guys
TELO cancer news https://www.stocktitan.net/sec-filings/TELO/8-k-telomir-pharmaceuticals-inc-reports-material-event-2e911b4b6f1b.html
$TELO with massive news there. Cure for Brest cancer I’m hearing. Huge
TELO - Telomir Pharmaceuticals Unveils Promising Cancer Treatment Discovery
TELO - am in at $2.05. May well be the play tomorrow
TELO - 8-k filling. PR to come. $2.05 now. Will it go bananas tomorrow?????????
Do we have any thoughts on TELO? Why did it go up yesterday?
Little known longevity biotech stock $TELO (pre-clinical) has 50-100x potential based on every study done so far. It is currently so cheap that throwing your monthly beer allowance for sh!ts and giggles and just holding it for 5 years could give you better returns than anything else. It was trialed on dogs last year and covered by a local news channel. See video here: [https://www.mysuncoast.com/2024/08/16/abc7-exclusive-new-study-reveals-promising-results-age-reversal-pill-dogs/](https://www.mysuncoast.com/2024/08/16/abc7-exclusive-new-study-reveals-promising-results-age-reversal-pill-dogs/)
Any opinions on TELO?
$TELO having a beauty moment up right now...
How do you see TELO? Will it go up more at the opening?
$TELO let’s gooo! 🚀 https://www.tipranks.com/news/company-announcements/telomir-pharmaceuticals-announces-promising-preclinical-findings
Just posted telo forgot to add this https://www.stocktitan.net/news/TELO/
$TELO if you can hold for a couple of years. It could 10x but only for patient investors
TELO volumes been going up and price is moving ! :-)
I haven't done much IPO stuff. I'll look into KRMN. Thanks for the tip, and congrats! Another couple of biotechs I have been swinging are KLTO and TELO, both down rn.
Does TELO really have a sign of going up
$TELO isn’t even a squeeze play. It’s a long term Giga bullish miracle drug pharmaceutical company that could literally be worth more than NVIDIA someday if their drug literally does anything.
Where do I find this tool - squeeze finder? I was wondering why TELO was up today. It was on my today's watch lists.
TELO was on squeeze finder along with this ticker
I dont know about all that, but I keep seeing TELO everywhere. Alerts and all.
Looking at $TELO, haven’t jumped in yet though
$TELO getting pumped or dumped at open?
TELO moving nicely in PM (in @2.03)
Watching **$TELO** PM 35% AH Telomir-1’s *emerging profile as a potential first-in-class epigenetic therapy* : https://www.sec.gov/ix?doc=/Archives/edgar/data/0001971532/000164117225025688/form8-k.htm Entered AH **$OTLK** -20% on a day **PDUFA LYTENAVA** (Aug 27), waiting for news. **(High risk)** Both didn’t really have any hype or serious run ups. NFA
TELO about to run tomorrow https://www.sec.gov/Archives/edgar/data/1971532/000164117225025688/form8-k.htm
Strong AH move for TELO, catalyst confirmed after close
$TELO dropped good news running rn
Any news on TELO?? I'm glad my sell order expired. 😂
Based on news do you results of their testing lately, I have a good feeling and position with TELO. Long term.
2 underrated stocks: **Stock 1** * $ACHR : 2x potential within 12 months * [https://www.investors.archer.com/news/news-details/2025/Archer-Accelerates-Defense-Program-with-Two-Strategic-Acquisitions-as-it-Pursues-Growing-Demand/default.aspx](https://www.investors.archer.com/news/news-details/2025/Archer-Accelerates-Defense-Program-with-Two-Strategic-Acquisitions-as-it-Pursues-Growing-Demand/default.aspx) **Stock 2** * $TELO: 10x-100x potential in 2-3 years * Longevity Potential - eventually, every human over 50 might use their product to live longer and healthier * [https://ir.telomirpharma.com/press-releases/](https://ir.telomirpharma.com/press-releases/) * [https://scr.zacks.com/news/news-details/2025/TELO-Announces-Another-Important-Breakthrough/default.aspx](https://scr.zacks.com/news/news-details/2025/TELO-Announces-Another-Important-Breakthrough/default.aspx) * [https://www.mysuncoast.com/2024/08/16/abc7-exclusive-new-study-reveals-promising-results-age-reversal-pill-dogs/](https://www.mysuncoast.com/2024/08/16/abc7-exclusive-new-study-reveals-promising-results-age-reversal-pill-dogs/) * [https://ir.telomirpharma.com/telomir-pharmaceuticals-to-participate-in-bio-2025-in-boston-as-company-prepares-for-ind-submission-and-advances-breakthrough-longevity-platform/](https://ir.telomirpharma.com/telomir-pharmaceuticals-to-participate-in-bio-2025-in-boston-as-company-prepares-for-ind-submission-and-advances-breakthrough-longevity-platform/)
$TELO will go to 100x in 2-3 years. Eventually, every human over 50 will use their product to live longer and healthier. The stock is dirt cheap right now and in 3 years, you might wish that you'd heard of it before Some Links: Their press releases: * [https://ir.telomirpharma.com/press-releases/](https://ir.telomirpharma.com/press-releases/) Article from Zacks small cap research (read the last statement of the article): * [https://scr.zacks.com/news/news-details/2025/TELO-Announces-Another-Important-Breakthrough/default.aspx](https://scr.zacks.com/news/news-details/2025/TELO-Announces-Another-Important-Breakthrough/default.aspx) Video of dramatic improvement in dogs: * [https://www.mysuncoast.com/2024/08/16/abc7-exclusive-new-study-reveals-promising-results-age-reversal-pill-dogs/](https://www.mysuncoast.com/2024/08/16/abc7-exclusive-new-study-reveals-promising-results-age-reversal-pill-dogs/)
Article from Zacks small cap research: [https://scr.zacks.com/news/news-details/2025/TELO-Announces-Another-Important-Breakthrough/default.aspx](https://scr.zacks.com/news/news-details/2025/TELO-Announces-Another-Important-Breakthrough/default.aspx)
TELO will go to 100x in 2-3 years. Eventually, every human over 50 will use their product to live longer and healthier. The stock is dirt cheap right now and in 3 years, you might wish that you'd heard of it before
BZAI and TELO will sky rocket
Am I seriously the only guy who's read about/noticed TELO? Gotta be honest, bought some yesterday and tanked a loss but I'm playing a decently long game with this
Got on the TELO train and let us see how this goes..
guys anyone bought TELO? I think it's gonna shoot up
I believe TELO is showing us what IXHL will be able to do. Absolutely launched!!!
Either the TELO trade is just beginning or it's over, not sure.
Guys..get on TELO. Huge upside with new drug news. already up over 100% pre-market.
What happened with TELO up 140 percent after hours
https://ir.telomirpharma.com/telomir-pharmaceuticals-prevents-cellular-aging-in-patient-derived-cells-from-children-with-progeria-an-ultra-rare-genetic-disorder-that-causes-rapid-aging/ Telomir Pharmaceuticals Prevents Cellular Aging in Patient-Derived Cells from Children with Progeria - an Ultra-Rare Genetic Disorder that Causes Rapid Aging - Telomir Pharmaceuticals, Inc. (TELO)
Telomir moving aftermarket after good phase-I data. $TELO
Check out this video: [https://www.mysuncoast.com/2024/08/16/abc7-exclusive-new-study-reveals-promising-results-age-reversal-pill-dogs/](https://www.mysuncoast.com/2024/08/16/abc7-exclusive-new-study-reveals-promising-results-age-reversal-pill-dogs/) Stock: $TELO (hit a low price today) An early stage company (see slide#25): [https://ir.telomirpharma.com/pechoagl/2025/06/Telomir-Full-Deck.pdf](https://ir.telomirpharma.com/pechoagl/2025/06/Telomir-Full-Deck.pdf) They continue to show progress: [https://ir.telomirpharma.com/press-releases/](https://ir.telomirpharma.com/press-releases/) It is a long shot but this could be a **100-bagger** in 2-5 years because if their longevity pill works, their market is all the humans and pets on the planet
* 100x TELO * 10x BBAI * 4x WRD * 3x PONY * 2x ACHR * 2x SOFI
Telomir Pharmaceuticals (TELO) today announced compelling preclinical results from a study evaluating its novel oral therapeutic, Telomir-1, in a genetically modified zebrafish model of age-related macular degeneration (AMD). Following a 14-day oral dosing regimen, Telomir-1 reversed central vision response and vision acuity, restored retinal degeneration and architecture, and significantly reduced oxidative stress—achieving improvements across several FDA-recognized surrogate endpoints relevant to AMD. The study utilized the Sen57wrn-/-ND6-/+ zebrafish model, which combines genetic mutations associated with premature aging (WRN), mitochondrial dysfunction (ND6), and chronic senescence (Sen57). These animals exhibit progressive retinal degeneration, visual impairment, and oxidative stress—closely modeling dry AMD and geographic atrophy in humans.
TELO - Longevity treatment
Telomir Pharmaceuticals TELO today announced it has secured $3 million in equity financing, through a direct investment by The Bayshore Trust, the Company’s largest shareholder. The transaction involved the purchase of 1 million restricted shares of the Company’s common stock at $3.00 per share, representing an 18% premium to Telomir’s closing share price of $2.54 on the date of execution. The transaction was structured as a straight restricted common stock transaction with no warrants, no discounts, and no convertible features.
Telomir Pharmaceuticals (TELO) continues to expand its potential portfolio and just announced that it had identified Telomir-Ag2 as a novel drug candidate for the treatment of bacterial infections. According to the company, Telomir-Ag2 is a stabilized Silver(II) complex that, in preclinical testing, showed broad-spectrum antimicrobial activity, including against MARSA (methicillin- and aminoglycoside-resistant *Staphylococcus aureus).* According to the CDC, MARSA is a drug-resistant variant responsible for infections in hospitals and in the US causes over 323,000 hospitalizations and more than 10,000 deaths per year. According to Verified Market Research the silver wound dressing market is expected to reach $1.36 billion by 2030, while the antimicrobial coatings market is expected to reach $33.7 billion by 2031.
Telomir Pharmaceuticals (TELO) today announced the identification of Telomir-Ag2 as a novel drug candidate for the treatment of bacterial infections, including those caused by drug-resistant pathogens. This follows Telomir’s recent breakthrough in stabilizing Silver(II) in a biologically compatible form using its proprietary Telomir-1 platform. Telomir-Ag2 is a stabilized Silver(II) complex that demonstrated broad-spectrum antimicrobial activity in preclinical studies, including against methicillin- and aminoglycoside-resistant Staphylococcus aureus (MARSA), one of the most challenging pathogens in clinical settings. “In the lab, Silver(II) has always shown remarkable antimicrobial potential, but it was considered too unstable for real-world use,” said Erez Aminov, CEO and Chairman of Telomir.
Update on Telomir Pharma (TELO): On Thursday, Rodman & Renshaw initiated coverage on Telomir Pharma shares, issuing a Buy rating with a price target of $15.00. The firm's valuation is based on a detailed analysis of the company's financial prospects and the potential of its Wilson's disease program. The assessment by Rodman & Renshaw estimates a net present value (NPV) of approximately $300 million for the Wilson's disease program, which translates to around $9 per share. This valuation takes into account a 30% probability adjustment and a 21% tax rate, extending through to 2044 and using a 15% discount rate. In addition to the Wilson's disease program, Rodman & Renshaw has recognized the inherent technology value of Telomir-1, the company's leading drug candidate. The technology value is appraised at $200 million, or $6 per share, reflecting the drug's potential for treating additional indications beyond Wilson's disease.
news on TELO [https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/telomir-pharmaceuticals-announces-significant-reduction-of-oxidative-s-986790](https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/telomir-pharmaceuticals-announces-significant-reduction-of-oxidative-s-986790)
Start doing research on peptides and longevity companies. Here is the purest longevity play - Telomir Pharmaceuticals (NASDAQ: TELO)